{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:32:46Z","timestamp":1778589166498,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2010,3,30]]},"DOI":"10.1161\/cir.0b013e3181daa7c9","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T04:09:20Z","timestamp":1268712560000},"page":"1379-1381","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Homocysteine Lowering in End-Stage Renal Disease"],"prefix":"10.1161","volume":"121","author":[{"given":"Lawrence","family":"de Koning","sequence":"first","affiliation":[{"name":"From the Departments of Nutrition (L.d.K., F.B.H.) and Epidemiology (F.B.H.), Harvard School of Public Health, Channing Laboratory, and the Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School (F.B.H.), Boston, Mass."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank B.","family":"Hu","sequence":"additional","affiliation":[{"name":"From the Departments of Nutrition (L.d.K., F.B.H.) and Epidemiology (F.B.H.), Harvard School of Public Health, Channing Laboratory, and the Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School (F.B.H.), Boston, Mass."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"111","volume":"56","year":"1969","unstructured":"McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56: 111\u2013128.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.16.2015"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02207.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.22.2720"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.108.162743"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000142725"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(03)00062-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/biof.17"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10588"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8100"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.21.12.2080"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7374.1202"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.16.2023"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.04.025"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7135.894"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905133401901"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17789-7"},{"key":"e_1_3_2_18_2","first-page":"S16","volume":"9","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998; 9 (suppl): S16\u2013S23.","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.01.266"},{"key":"e_1_3_2_20_2","first-page":"1586","volume":"45","year":"2007","unstructured":"Righetti M. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients. Clin Chem Lab Med. 2007; 45: 1586\u20131589.","journal-title":"Clin Chem Lab Med"},{"key":"e_1_3_2_21_2","first-page":"1432","volume":"112","year":"2010","unstructured":"Heinz J, Kropf S, Domr\u00f6se U, Westphal S, Borucki K, Luley C, Neumann KH, Dierkes J. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation. 2010; 112: 1432\u20131438.","journal-title":"Circulation"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.08.010"},{"key":"e_1_3_2_23_2","unstructured":"What is homocysteine? American Heart Association. http:\/\/www. americanheart.org\/presenter.jhtml?identifier=535. Accessed February 18 2010."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.38"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3945\/jn.108.096511"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(97)00244-X"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00508.x"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIR.0b013e3181daa7c9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:13:08Z","timestamp":1715559188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0b013e3181daa7c9"}},"subtitle":["Is There Any Cardiovascular Benefit?"],"short-title":[],"issued":{"date-parts":[[2010,3,30]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,3,30]]}},"alternative-id":["10.1161\/CIR.0b013e3181daa7c9"],"URL":"https:\/\/doi.org\/10.1161\/cir.0b013e3181daa7c9","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,30]]},"assertion":[{"value":"2010-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}